The global isothermal nucleic acid amplification technology (INAAT) market is likely to boost due to the growing demand for molecular diagnostics

The global isothermal nucleic acid amplification technology (INAAT) market size was valued at USD 1,729.0 million in 2019 and is projected to grow at a CAGR of 13.8% during the forecast period, 2020-2027. It is due to the boom in demand for INAAT for diseases diagnosis. Further, the increasing applications of INAAT and the use of advanced devices in forensics, medicine, and research will augment the growth of the global INAAT industry in the forecast periods. Additionally, the increasingly wide range of INAAT applications in various fields, including cancer diagnosis, blood screening & transfusions, and Infectious diseases, is expected to foster global market growth. INAAT has promising application prospects in the healthcare and life science industry. With the expansion of isothermal nucleic acid amplification technology and the increase in people's medical consumption, expenditure will bolster the growth of the global INAAT market share in the coming years. Moreover, the government's interference in improving healthcare infrastructure and swelling investments in the R&D sector will stimulate the market share. Furthermore, the benefits of INAAT, such as accurate & rapid testing results and a decrease in development cost & time, will accelerate the growth of the global isothermal nucleic acid amplification technology (INAAT) industry.

?See Full Report of Description and Table of Content at: https://www.shingetsuresearch.com/isothermal-nucleic-acid-amplification-technology-inaat-market/

Product Overview in the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market

The global INNAT market is segregated into assays, kits & reagents, and instruments or systems based on the product. The assay, kits, and reagents segment estimated to witness the highest growth over the analysis timeframe due to repetitive consumption of consumables and broad usage in hospitals & primarily healthcare settings as compared to instruments. Additionally, the increasing number of infectious diseases coupled with the rising demand for diseases diagnosis is expected to drive the market.

Technology Overview in the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market

The global INAAT market is categorized into LAMP, SDA, NASBA, HAD, TMA, and other technologies based on the type of technology. The transcription-mediated amplification (TMA) segment held a significant market share in 2019 and will gain maximum market revenue by 2027. It is attributable to the rising demand for infectious diseases screening &diagnosis with less processing time, fewer steps, and faster results. Additionally, it is highly adopted in the clinical laboratory to perform nucleic acid test (NAT) assays for blood screening.

Application Overview in the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market

Based on the application, the global INAAT market is classified into Infectious diseases diagnosis, blood screening, cancer, and other applications. The infectious diseases diagnosis is expected to be the highest revenue share for INAAT during the forecast period. The segment's growth is preferably attributed to the increased adoption of isothermal amplification coupled with the growing incidence of HIV, hepatitis A & B, &STDs and the rising need for rapid testing of infectious diseases. The blood screening will witness a lucrative growth rate in the estimated period due to generating blood transfusions across the globe.

End-User Overview in the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market

The global INAAT market is segmented into hospitals, reference laboratories, and academic & research institutes based on the end-user. The hospital & surgical centers segment will dominate the global INAAT market by 2027. Due to the rising demand for hospital-based diagnosis, they offer quick & accurate test results compared to reference laboratories.

Regional Overview in the Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market

The global INAAT market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America is estimated to project considerable growth over 2020-2026. It is owing to the rising prevalence of infectious diseases, modernization of healthcare infrastructure, and increasing genome-based drug development activities. The Asia Pacific will capture a significant share of the INAAT market by 2027. Due to rising disposable income, growing demand for advanced diagnosis & blood screening techniques, and rapid expansion in healthcare infrastructure.

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market: Competitive Landscape

Companies such as Becton, BioMérieux SA, DiaSorinS.p.A., Abbott Laboratories, Eiken Chemical CO LTD, HologicInc, Grifols,?Meridian Bioscience, Quidel Corporation, QIAGEN, Tecan Trading AG, Thermo Fisher Scientific Inc, GE Healthcare, and New England Biolabs are the key players in the global INAAT market.